The effect of the autoimmunity-associated gene, PTPN22, on a BXSB-derived model of lupus

Clinical Immunology

Volumn 156, Issue 1, 2015, Pages 65-73

  Maine, Christian J ^a   Marquardt, Kristi ^a   Scatizzi, John C ^a   Pollard, K Michael ^a   Kono, Dwight H ^a   Sherman, Linda A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Autoantibodies; BXSB; PTPN22; Systemic lupus erythematosus; T follicular helper cells; Tolerance

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PTPN22 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW CELL; CELL SURVIVAL; CHROMOSOME 1; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE DUPLICATION; GERMINAL CENTER; INFLAMMATORY CELL; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; Y CHROMOSOME; ANIMAL; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, KNOCKOUT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 84911882834     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.11.003     Document Type: Article

References (46)

1. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 2004, 36:337-338.
2. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 2004, 75:330-337.
3. Kyogoku C., Langefeld C.D., Ortmann W.A., Lee A., Selby S., Carlton V.E., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 2004, 75:504-507.
4. Hasegawa K., Martin F., Huang G., Tumas D., Diehl L., Chan A.C. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004, 303:685-689.
5. Zhang J., Zahir N., Jiang Q., Miliotis H., Heyraud S., Meng X., et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat. Genet. 2011, 43:902-907.
6. Zheng P., Kissler S. PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant. Diabetes 2013, 62:896-904.
7. Yeh L.T., Miaw S.C., Lin M.H., Chou F.C., Shieh S.J., Chuang Y.P., et al. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice. J. Immunol. 2013, 191:594-607.
8. Wu D.J., Zhou W., Enouz S., Orru V., Stanford S.M., Maine C.J., et al. Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells. PLoS One 2014, 9:e86677.
9. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 2009, 41:1228-1233.
10. Lea W.W., Lee Y.H. The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update. Lupus 2011, 20:51-57.
11. Zheng J., Ibrahim S., Petersen F., Yu X. Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue. Genes Immunol. 2012, 13:641-652.
12. Baca V., Velazquez-Cruz R., Salas-Martinez G., Espinosa-Rosales F., Saldana-Alvarez Y., Orozco L. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immunol. 2006, 7:693-695.
13. Namjou B., Kim-Howard X., Sun C., Adler A., Chung S.A., Kaufman K.M., et al. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PLoS One 2013, 8:e69404.
14. Stanford S.M., Krishnamurthy D., Falk M.D., Messina R., Debnath B., Li S., et al. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J. Med. Chem. 2011, 54:1640-1654.
15. Vang T., Liu W.H., Delacroix L., Wu S., Vasile S., Dahl R., et al. LYP inhibits T-cell activation when dissociated from CSK. Nat. Chem. Biol. 2012, 8:437-446.
16. Brownlie R.J., Miosge L.A., Vassilakos D., Svensson L.M., Cope A., Zamoyska R. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci. Signal. 2012, 5:ra87.
17. Maine C.J., Hamilton-Williams E.E., Cheung J., Stanford S.M., Bottini N., Wicker L.S., et al. PTPN22 alters the development of regulatory T cells in the thymus. J. Immunol. 2012, 188:5267-5275.
18. Arechiga A.F., Habib T., He Y., Zhang X., Zhang Z.Y., Funk A., et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J. Immunol. 2009, 182:3343-3347.
19. Dai X., James R.G., Habib T., Singh S., Jackson S., Khim S., et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J. Clin. Invest. 2013, 123:2024-2036.
20. Habib T., Funk A., Rieck M., Brahmandam A., Dai X., Panigrahi A.K., et al. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J. Immunol. 2012, 188:487-496.
21. Menard L., Saadoun D., Isnardi I., Ng Y.S., Meyers G., Massad C., et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest. 2011, 121:3635-3644.
22. Rieck M., Arechiga A., Onengut-Gumuscu S., Greenbaum C., Concannon P., Buckner J.H. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol. 2007, 179:4704-4710.
23. Maine C.J., Marquardt K., Cheung J., Sherman L.A. PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells. J. Immunol. 2014, 192:1415-1424.
24. Wang Y., Shaked I., Stanford S.M., Zhou W., Curtsinger J.M., Mikulski Z., et al. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity 2013, 39:111-122.
25. Zikherman J., Hermiston M., Steiner D., Hasegawa K., Chan A., Weiss A. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J. Immunol. 2009, 182:4093-4106.
26. Theofilopoulos A.N., Dixon F.J. Murine models of systemic lupus erythematosus. Adv. Immunol. 1985, 37:269-390.
27. Dixon F.J., Andrews B.S., Eisenberg R.A., McConahey P.J., Theofilopoulos A.N., Wilson C.B. Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthritis Rheum. 1978, 21:S64-S67.
28. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006, 312:1669-1672.
29. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9970-9975.
30. Haywood M.E., Hogarth M.B., Slingsby J.H., Rose S.J., Allen P.J., Thompson E.M., et al. Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum. 2000, 43:349-355.
31. Haywood M.E., Rogers N.J., Rose S.J., Boyle J., McDermott A., Rankin J.M., et al. Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease. J. Immunol. 2004, 173:4277-4285.
32. Kono D.H., Haraldsson M.K., Lawson B.R., Pollard K.M., Koh Y.T., Du X., et al. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12061-12066.
33. Hudgins C.C., Steinberg R.T., Klinman D.M., Reeves M.J., Steinberg A.D. Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J. Immunol. 1985, 134:3849-3854.
34. Crow M.K. Type I, interferon in the pathogenesis of lupus. J. Immunol. 2014, 192:5459-5468.
35. Kono D.H., Baccala R., Theofilopoulos A.N. TLRs and interferons: a central paradigm in autoimmunity. Curr. Opin. Immunol. 2013, 25:720-727.
36. Pollard K.M., Hultman P., Toomey C.B., Cauvi D.M., Hoffman H.M., Hamel J.C., et al. Definition of IFN-gamma-related pathways critical for chemically-induced systemic autoimmunity. J. Autoimmun. 2012, 39:323-331.
37. Andrews B.S., Eisenberg R.A., Theofilopoulos A.N., Izui S., Wilson C.B., McConahey P.J., et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 1978, 148:1198-1215.
38. Baccala R., Gonzalez-Quintial R., Schreiber R.D., Lawson B.R., Kono D.H., Theofilopoulos A.N. Anti-IFN-alpha/beta receptor antibody treatment ameliorates disease in lupus-predisposed mice. J. Immunol. 2012, 189:5976-5984.
39. Niewold T.B. Interferon alpha as a primary pathogenic factor in human lupus. J. Interferon Cytokine Res. 2011, 31:887-892.
40. Ostendorf B., Iking-Konert C., Kurz K., Jung G., Sander O., Schneider M. Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis. Ann. Rheum. Dis. 2005, 64:630-633.
41. Postal M., Appenzeller S. The role of Tumor Necrosis Factor-alpha (TNF-alpha) in the pathogenesis of systemic lupus erythematosus. Cytokine 2011, 56:537-543.
42. Stanford S.M., Bottini N. PTPN22: the archetypal non-HLA autoimmunity gene. Nat. Rev. Rheumatol. 2014, 10(10):602-611.
43. Rubtsov A.V., Rubtsova K., Fischer A., Meehan R.T., Gillis J.Z., Kappler J.W., et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity. Blood 2011, 118:1305-1315.
44. Waters S.T., McDuffie M., Bagavant H., Deshmukh U.S., Gaskin F., Jiang C., et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J. Exp. Med. 2004, 199:255-264.
45. Dai C., Wang H., Sung S.S., Sharma R., Kannapell C., Han W., et al. Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure. Clin. Immunol. 2014, 154:66-71.
46. Ge Y., Jiang C., Sung S.S., Bagavant H., Dai C., Wang H., et al. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J. Exp. Med. 2013, 210:2387-2401.